A Gupta1, K M Eastham, N Wrightson, D A Spencer. 1. Department of Respiratory Paediatrics, Freeman Hospital, Freeman Road, Heaton, Newcastle upon Tyne, United Kingdom.
Abstract
BACKGROUND: Hypomagnesaemia in patients with cystic fibrosis (CF) is under-recognized although the true incidence is unknown. Many patients are asymptomatic, although severe deficiency may be associated with muscle weakness, cramps and tetany. Hypomagnesaemia may be a risk factor for post-transplant complications including convulsions, which may be exacerbated by the use of calcineurin inhibitors. The aims of the present study were to describe serum magnesium levels and to investigate the relationship between magnesium levels and age, and renal function measurements in patients with CF referred to a transplant centre for lung transplant assessment. METHODS: We reviewed the data of all 106 CF patients referred for transplant assessment from January 1995 to December 2003. Demographic and biochemical data were recorded and the explanatory variables were subjected to univariate analysis and linear regression analysis. RESULTS: Mean serum magnesium level was 0.75 mmol/L (range 0.46-1.03, normal range 0.74-1.1). 57% of patients had hypomagnesaemia. Serum magnesium levels were not associated with age, serum creatinine or GFR. CONCLUSIONS: Hypomagnesaemia is a common finding in patients with CF referred for lung transplant assessment. Serum magnesium levels should be monitored in all CF patients being referred for lung transplant irrespective of the results of other renal function tests.
BACKGROUND: Hypomagnesaemia in patients with cystic fibrosis (CF) is under-recognized although the true incidence is unknown. Many patients are asymptomatic, although severe deficiency may be associated with muscle weakness, cramps and tetany. Hypomagnesaemia may be a risk factor for post-transplant complications including convulsions, which may be exacerbated by the use of calcineurin inhibitors. The aims of the present study were to describe serum magnesium levels and to investigate the relationship between magnesium levels and age, and renal function measurements in patients with CF referred to a transplant centre for lung transplant assessment. METHODS: We reviewed the data of all 106 CF patients referred for transplant assessment from January 1995 to December 2003. Demographic and biochemical data were recorded and the explanatory variables were subjected to univariate analysis and linear regression analysis. RESULTS: Mean serum magnesium level was 0.75 mmol/L (range 0.46-1.03, normal range 0.74-1.1). 57% of patients had hypomagnesaemia. Serum magnesium levels were not associated with age, serum creatinine or GFR. CONCLUSIONS: Hypomagnesaemia is a common finding in patients with CF referred for lung transplant assessment. Serum magnesium levels should be monitored in all CF patients being referred for lung transplant irrespective of the results of other renal function tests.
Authors: Shubham Chakravarty; Cameron N Melton; Adam Bailin; Timothy L Yahr; Gregory G Anderson Journal: J Bacteriol Date: 2017-10-31 Impact factor: 3.490
Authors: Kerstin Pohl; Elaine Hayes; Joanne Keenan; Michael Henry; Paula Meleady; Kevin Molloy; Bakr Jundi; David A Bergin; Cormac McCarthy; Oliver J McElvaney; Michelle M White; Martin Clynes; Emer P Reeves; Noel G McElvaney Journal: Blood Date: 2014-06-16 Impact factor: 22.113
Authors: F Huguet; M L Calvez; N Benz; S Le Hir; O Mignen; P Buscaglia; F D Horgen; C Férec; M Kerbiriou; P Trouvé Journal: Cell Mol Life Sci Date: 2016-02-13 Impact factor: 9.207
Authors: Marlene Fabiola Escobedo-Monge; Enrique Barrado; Joaquín Parodi-Román; María Antonieta Escobedo-Monge; María Carmen Torres-Hinojal; José Manuel Marugán-Miguelsanz Journal: Nutrients Date: 2022-07-18 Impact factor: 6.706
Authors: Arianna Pompilio; Domenico Ciavardelli; Valentina Crocetta; Ada Consalvo; Roberta Zappacosta; Carmine Di Ilio; Giovanni Di Bonaventura Journal: PLoS One Date: 2014-02-28 Impact factor: 3.240